Gilead Sciences, Inc. announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumonia. This...
Read moreOxford Biomedica plc, a leading gene and cell therapy group, announced that it has signed a Collaboration Agreement with the...
Read moreTakeda Pharmaceutical Company Limited announced it will orally present the results of two studies at the 25th Congress of the...
Read moreKite, a Gilead Company announced it has received approval to implement a variation to the Yescarta® (axicabtagene ciloleucel) Marketing Authorization...
Read moreCorning Incorporated will receive $204 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of...
Read moreModerna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of...
Read moreEli Lilly and Company announced its partner Junshi Biosciences has dosed the first healthy volunteer in a study of a...
Read moreFUJIFILM Corporation will make a major capital investment of approximately 100 billion yen (928 million USD) in the Denmark site...
Read moreSun Pharmaceutical Industries Ltd. announced that it has commenced Phase II clinical trial on AQCH, a phytopharmaceutical (plant derived) drug...
Read moreIn the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.